(NVMI) Nova - Ratings and Ratios
Metrology Platforms, Dimensional Metrology, Films Metrology, Materials Metrology, Chemical Metrology
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 55.2% |
| Value at Risk 5%th | 87.1% |
| Relative Tail Risk | -4.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.22 |
| Alpha | 47.08 |
| CAGR/Max DD | 1.30 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.436 |
| Beta | 1.755 |
| Beta Downside | 1.742 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.79% |
| Mean DD | 9.78% |
| Median DD | 6.29% |
Description: NVMI Nova November 03, 2025
Nova Ltd. (NASDAQ:NVMI) designs, develops, produces, and sells process-control metrology systems that enable dimensional, film, and material measurements across key semiconductor manufacturing steps such as lithography, etch, CMP, deposition, electro-chemical plating, and advanced packaging. The company serves logic, foundry, memory, packaging, and equipment-maker customers in Taiwan, the United States, China, Korea, and other global markets.
In FY 2023 Nova reported revenue of $124 million, a 9 % year-over-year increase, driven primarily by higher demand for its advanced packaging metrology solutions. Gross margin expanded to 58 % versus 53 % in FY 2022, reflecting a shift toward higher-value product mix and improved manufacturing efficiency.
The semiconductor equipment market is being propelled by two macro-level forces: (1) the AI-driven surge in demand for high-performance compute chips, which raises total wafer starts and capex budgets, and (2) the industry-wide transition to heterogeneous integration and advanced packaging, which elevates the importance of precise metrology. Nova’s focus on these high-growth nodes positions it to capture a larger share of the projected $120 billion equipment spend through 2028.
If you want a data-rich, independent view of Nova’s valuation and risk profile, a quick look at ValueRay’s analyst dashboard can help you triangulate the numbers before making a decision.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (245.0m TTM) > 0 and > 6% of Revenue (6% = 51.2m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -3.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 132.5% (prev 86.35%; Δ 46.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 254.6m > Net Income 245.0m (YES >=105%, WARN >=100%) |
| Net Debt (362.1m) to EBITDA (278.1m) ratio: 1.30 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.58 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (32.5m) change vs 12m ago 0.72% (target <= -2.0% for YES) |
| Gross Margin 57.10% (prev 57.39%; Δ -0.29pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.84% (prev 45.89%; Δ 0.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 159.7 (EBITDA TTM 278.1m / Interest Expense TTM 1.61m) >= 6 (WARN >= 3) |
Altman Z'' 6.37
| (A) 0.49 = (Total Current Assets 1.45b - Total Current Liabilities 315.5m) / Total Assets 2.31b |
| (B) 0.35 = Retained Earnings (Balance) 798.1m / Total Assets 2.31b |
| (C) 0.14 = EBIT TTM 257.7m / Avg Total Assets 1.82b |
| (D) 1.03 = Book Value of Equity 1.17b / Total Liabilities 1.14b |
| Total Rating: 6.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.40
| 1. Piotroski 4.50pt |
| 2. FCF Yield 2.84% |
| 3. FCF Margin 27.04% |
| 4. Debt/Equity 0.75 |
| 5. Debt/Ebitda 1.30 |
| 6. ROIC - WACC (= 26.87)% |
| 7. RoE 23.46% |
| 8. Rev. Trend 83.98% |
| 9. EPS Trend 88.86% |
What is the price of NVMI shares?
Over the past week, the price has changed by +6.19%, over one month by -12.39%, over three months by +18.56% and over the past year by +76.28%.
Is NVMI a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NVMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 365.8 | 18.9% |
| Analysts Target Price | 365.8 | 18.9% |
| ValueRay Target Price | 451.6 | 46.8% |
NVMI Fundamental Data Overview November 25, 2025
P/E Trailing = 36.371
P/E Forward = 28.6533
P/S = 9.7513
P/B = 7.1025
Beta = 1.829
Revenue TTM = 852.7m USD
EBIT TTM = 257.7m USD
EBITDA TTM = 278.1m USD
Long Term Debt = 730.7m USD (from longTermDebt, last quarter)
Short Term Debt = 98.1m USD (from shortTermDebt, last quarter)
Debt = 883.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 362.1m USD (from netDebt column, last quarter)
Enterprise Value = 8.11b USD (8.32b + Debt 883.7m - CCE 1.09b)
Interest Coverage Ratio = 159.7 (Ebit TTM 257.7m / Interest Expense TTM 1.61m)
FCF Yield = 2.84% (FCF TTM 230.5m / Enterprise Value 8.11b)
FCF Margin = 27.04% (FCF TTM 230.5m / Revenue TTM 852.7m)
Net Margin = 28.73% (Net Income TTM 245.0m / Revenue TTM 852.7m)
Gross Margin = 57.10% ((Revenue TTM 852.7m - Cost of Revenue TTM 365.8m) / Revenue TTM)
Gross Margin QoQ = 56.73% (prev 57.84%)
Tobins Q-Ratio = 3.51 (Enterprise Value 8.11b / Total Assets 2.31b)
Interest Expense / Debt = 0.18% (Interest Expense 1.61m / Debt 883.7m)
Taxrate = 16.32% (12.0m / 73.4m)
NOPAT = 215.7m (EBIT 257.7m * (1 - 16.32%))
Current Ratio = 4.58 (Total Current Assets 1.45b / Total Current Liabilities 315.5m)
Debt / Equity = 0.75 (Debt 883.7m / totalStockholderEquity, last quarter 1.17b)
Debt / EBITDA = 1.30 (Net Debt 362.1m / EBITDA 278.1m)
Debt / FCF = 1.57 (Net Debt 362.1m / FCF TTM 230.5m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.62% (Net Income 245.0m / Total Assets 2.31b)
RoE = 23.46% (Net Income TTM 245.0m / Total Stockholder Equity 1.04b)
RoCE = 14.52% (EBIT 257.7m / Capital Employed (Equity 1.04b + L.T.Debt 730.7m))
RoIC = 38.16% (NOPAT 215.7m / Invested Capital 565.2m)
WACC = 11.30% (E(8.32b)/V(9.20b) * Re(12.48%) + D(883.7m)/V(9.20b) * Rd(0.18%) * (1-Tc(0.16)))
Discount Rate = 12.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.70%
[DCF Debug] Terminal Value 68.36% ; FCFE base≈209.8m ; Y1≈258.8m ; Y5≈441.5m
Fair Price DCF = 131.4 (DCF Value 3.90b / Shares Outstanding 29.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 88.86 | EPS CAGR: 20.30% | SUE: 0.36 | # QB: 0
Revenue Correlation: 83.98 | Revenue CAGR: 17.80% | SUE: 0.72 | # QB: 0
Additional Sources for NVMI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle